Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4433-4441

  Patel, Samirkumar R ^a   Berezovsky, Damian E ^b   McCarey, Bernard E ^b   Zarnitsyn, Vladimir ^a   Edelhauser, Henry F ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXTRAN; FLUORESCEIN; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; CORNEA LIMBUS; DRUG ADMINISTRATION ROUTE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; EYE FUNDUS; FLUORESCENCE; FLUOROPHOTOMETRY; HISTOLOGY; MOLECULAR WEIGHT; NEEDLE; NONHUMAN; POSTERIOR EYE CHAMBER; PRIORITY JOURNAL; RABBIT; RETINA; SAFETY; SUPRACHOROIDAL SPACE ADMINISTRATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID; DEXTRANS; DRUG DELIVERY SYSTEMS; FLUORESCEIN; FLUORESCEINS; FLUORESCENCE; FLUOROPHOTOMETRY; INJECTIONS, INTRAOCULAR; NEEDLES; POSTERIOR EYE SEGMENT; RABBITS;

EID: 84863766409     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9872     Document Type: Article

References (24)

1. Friedman DS, O'Colmain B, Tomany SC, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008;126:1740-1747.
3. Chappelow AV, Kaiser PK. Neovascular age-related macular degeneration: potential therapies. Drugs. 2008;68:1029-1036.
4. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina. 2009;29:875-912.
5. Kuno N, Fujii S. Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging. 2010;27:117-134.
6. Lee S, Hughes P, Ross A, Robinson M. Biodegradable implants for sustained drug release in the eye. Pharm Res. 2010;27: 2043-2053.
7. Yasukawa T, Ogura Y. Medical devices for the treatment of eye diseases. Handb Exp Pharmacol. 2010;469-489.
8. Kim SH, Galban CJ, Lutz RJ, et al. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest Ophthalmol Vis Sci. 2007;48:808-814.
9. Olsen TW, Feng X, Warner K, et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol. 2006;142:777-787.
10. Einmahl S, Savoldelli M, D'Hermies F, Tabatabay C, Gurny R, Behar-Cohen F. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci. 2002;43:1533-1539.
11. Hou J, Tao Y, Jiang YR, Wang K. In vivo and in vitro study of suprachoroidal fibrin glue. Jpn J Ophthalmol. 2009;53:640-647.
12. Gilger BC, Salmon JH, Wilkie DA, et al. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci. 2006;47:2596-2605.
13. Olsen TW, Feng X, Wabner K, Csaky K, Pambuccian S, Cameron JD. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol Vis Sci. 2011;52:4749-4756.
14. Patel SR, Lin AS, Edelhauser HF, Prausnitz MR. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res. 2011;28:166-176.
15. Jiang J, Moore JS, Edelhauser HF, Prausnitz MR. Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res. 2009;26:395-403.
16. Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv. 2006;3:275-287.
17. Kuppermann B. Implants can deliver corticosteroids, pharmacological agents. Retina Today. 2007;27-31.
18. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol. 2005;40:63-68.
19. Holekamp NM, Thomas MA, Pearson A. The safety profile of long-term, high-dose intraocular corticosteroid delivery. Am J Ophthalmol. 2005;139:421-428.
20. Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 2011;47:66-80.
21. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
22. Brubaker RF, Pederson JE. Ciliochoroidal detachment. Surv Ophthalmol. 1983;27:281-289.
23. Bill A, Sperber G, Ujiie K. Physiology of the choroidal vascular bed. Int Ophthalmol. 1983;6:101-107.
24. Pederson JE, Gaasterland DE, MacLellan HM. Experimental ciliochoroidal detachment. Effect on intraocular pressure and aqueous humor flow. Arch Ophthalmol. 1979;97:536-541.